Upstream Processing

Dec 23, 2014
By BioPharm International Editors
Protein Sciences will evaluate sourcing Flublok from its Japanese licensee, UMN Pharma, which already runs a large-scale facility for the vaccine.
Dec 19, 2014
By BioPharm International Editors
The Cell Therapy Catapult, a UK non-profit center for advancing cell and gene therapies, will manage the manufacturing center, which will be used for late-phase clinical trials and commercial supply.
Nov 01, 2014
Challenges remain for virus removal and validation.
Oct 01, 2014
Fed-batch processes were scaled up from traditional bench-scale bioreactors to large-scale single-use systems.
Sep 01, 2014
Careful selection of downstream processing conditions is a must.
May 01, 2014
New human and plant-based expressions systems can enable faster product development and improve quality at potentially lower costs.
May 01, 2014
New approaches to vaccine production are targeting rapid supply for pandemic situations and broadly effective therapeutic treatments.
Apr 01, 2014
The biopharmaceutical industry is developing a new approach to controlling variability in raw materials.
Apr 01, 2014
A review of the past year's trends in biopharmaceutical approvals shows an above average approval rate.